FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula (I):
where: ♦ R1 denotes a phenyl group or a thienyl group, ♦ R2 denotes a hydrogen atom or a halogen atom, n denotes an integer equal to 0, 1 or 2, ♦ J represents a -C(O)- group, -CH(R3)- group or -SO2- group, ♦ R3 represents a hydrogen atom or a linear or branched (C1-C6)alkyl group, ♦ K represents a bond or -Cy1- group, ♦ L represents a -Cu2 group or -CH2-Cy2 group, ♦ W represents a group where:
■ represents
or
,
■ X represents carbon atom or a nitrogen atom, ■ R4 represents a hydrogen atom, a halogen atom, a linear or branched (C1-C6)alkyl group, a linear or branched (C2-C6)alkenyl group, a linear or branched (C2-C6)alkynyl group, -Y1-NR6R7 group, -Y1-OR6 group, a linear or branched halogen (C1-C6)alkyl group, an oxo group, -Y1-Cu3 group, -Cy3-R7 group, -Cy3-OR7 group, or -Y1-NR6-C(O)-R7 group, ■ R5 represents a hydrogen atom, a halogen atom, or a linear or branched (C1-C6)alkyl group, ■ R6 is a hydrogen atom or a linear or branched (C1-C6) alkyl group, ■ R7 is a hydrogen atom, a linear or branched (C1-C6)alkyl group or -Y2-Cy4 group, ■ Y1 and Y2 independently represent a bond or a linear or branched (C1-C4)alkylene group (values of the remaining radicals see paragraph 1 of formula), which is a USP7 protein activity inhibitor, as well as pharmaceutical compositions and combinations containing said protein.
EFFECT: novel (hetero)aryl-substituted piperidinyl derivatives, a method for preparing them and pharmaceutical compositions containing them are disclosed.
32 cl, 1 tbl, 1013 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL PIPERIDINYL DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2017 |
|
RU2743163C2 |
NOVEL INDOLYSIN COMPOUNDS, METHOD FOR PRODUCING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2014 |
|
RU2693629C2 |
NOVEL ISOINDOLINE OR ISOQUINOLINE COMPOUNDS, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2014 |
|
RU2689305C2 |
SUBSTITUTED PYRROLIDIN-2-CARBOXAMIDE | 2011 |
|
RU2564022C2 |
NEW INDOLIZINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2013 |
|
RU2646223C2 |
NOVEL PHOSPHATE COMPOUNDS, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2617682C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
AZASPIROALKANE DERIVATIVES METALLOPROTEASE INHIBITORS | 2004 |
|
RU2379303C2 |
NOVEL PYRROLE COMPOUNDS, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2607788C2 |
METHOD FOR PRODUCING TOFACITINIB AND ITS INTERMEDIATES | 2020 |
|
RU2810976C1 |
Authors
Dates
2021-02-04—Published
2017-06-09—Filed